Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 2Other hematologic neoplasm 1

Conditions

Febrile Neutropenia 3Neutropenia 2Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Neoplasms 1Fever 1

Interventions

liposomal amphotericin B 2Cefepime 2Caspofungin 2ofatumumab 1Vancomycin 1Tazobactam 1Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Moxifloxacin 1Metformin 1Meropenem 1Mannose-Binding Lectin 1Levofloxacin 1Lenalidomide 1Itraconazole 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Ciprofloxacin 1Cilastatin, Imipenem Drug Combination 1Ceftazidime 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fever × Ceftazidime × Other hematologic neoplasm × Clear all
NCT04187755 2019-12-06

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

Indonesia University

Phase 4 Completed
72 enrolled
Classical hematologyOther hematologic neoplasm

Fever, Leukemia, Neoplasms, Neutropenia, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡